BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6112710)

  • 1. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion.
    Mandarino L; Stenner D; Blanchard W; Nissen S; Gerich J; Ling N; Brazeau P; Bohlen P; Esch F; Guillemin R
    Nature; 1981 May; 291(5810):76-7. PubMed ID: 6112710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic beta-cell somatostatin receptors.
    Thermos K; Meglasson MD; Nelson J; Lounsbury KM; Reisine T
    Am J Physiol; 1990 Aug; 259(2 Pt 1):E216-24. PubMed ID: 1974386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs.
    Gordin A; Meyers C; Arimura A; Coy DH; Schally AV
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):833-41. PubMed ID: 335762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by cyclosporine of insulin secretion--a beta cell-specific alteration of islet tissue function.
    Gillison SL; Bartlett ST; Curry DL
    Transplantation; 1991 Nov; 52(5):890-5. PubMed ID: 1683035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central factors in the control of insulin and glucagon secretion.
    Porte D; Woods SC; Chen M; Smith PH; Ensinck JW
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):127-33. PubMed ID: 775499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of somatostatin inhibition of insulin and glucagon secretion.
    Bhathena SJ; Perrino PV; Voyles NR; Smith SS; Wilkins SD; Coy DH; Schally AV; Recant L
    Diabetes; 1976 Nov; 25(11):1031-40. PubMed ID: 992224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin-28: selective action on the pancreatic beta-cell and brain.
    Brown M; Rivier J; Vale W
    Endocrinology; 1981 Jun; 108(6):2391-6. PubMed ID: 6112138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.
    Brown M; Rivier J; Vale W
    Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biological activity of catfish pancreatic somatostatin.
    Oyama H; Martin J; Sussman K; Weir GC; Permutt A
    Regul Pept; 1981 Mar; 1(6):387-96. PubMed ID: 6112779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog.
    Buchs A; Märki F; Keller U
    Regul Pept; 1982 Aug; 4(3):117-26. PubMed ID: 6127755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
    Johnson DG; Ensinck JW; Koerker D; Palmer J; Goodner CJ
    Endocrinology; 1975 Feb; 96(2):370-4. PubMed ID: 1089535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of somatostatin action on insulin release. V. Effect of somatostatin analogues on arginine induced release of insulin and glucagon from the perfused rat pancreas.
    Efendić S; Lins PE; Luft R; Sievertsson H; Westin-Sjödal G
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):579-86. PubMed ID: 194446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of alpha- and beta-cell secretory responses in islets isolated with collagenase and in the isolated perfused pancreas of rats.
    Norfleet WT; Pagliara AS; Haymond MW; Matschinsky F
    Diabetes; 1975 Nov; 24(11):961-70. PubMed ID: 171190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of K+ and arginine on insulin, glucagon, and somatostatin release from the in vitro perfused rat pancreas.
    Frankel BJ; Heldt AM; Grodsky GM
    Endocrinology; 1982 Feb; 110(2):428-31. PubMed ID: 6120069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.
    Afargan M; Janson ET; Gelerman G; Rosenfeld R; Ziv O; Karpov O; Wolf A; Bracha M; Shohat D; Liapakis G; Gilon C; Hoffman A; Stephensky D; Oberg K
    Endocrinology; 2001 Jan; 142(1):477-86. PubMed ID: 11145612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.
    Qader SS; Håkanson R; Rehfeld JF; Lundquist I; Salehi A
    Regul Pept; 2008 Feb; 146(1-3):230-7. PubMed ID: 17942170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of somatostatin-28 and somatostatin-14 on basal growth hormone release and pancreatic function in immature ducks (Anas platyrhynchos).
    Strosser MT; Harvey S; Foltzer C; Mialhe P
    Gen Comp Endocrinol; 1984 Nov; 56(2):265-70. PubMed ID: 6150878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
    Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET; Sandler S
    Regul Pept; 2007 Jan; 138(1):1-9. PubMed ID: 16935361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of glucagon release by addition of anti-stomatostatin serum to islets of Langerhans in vitro.
    Barden N; Lavoie M; Dupont A; Côté J; Côté JP
    Endocrinology; 1977 Aug; 101(2):635-8. PubMed ID: 328268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.